Clinical trial
A Randomised Controlled Trial of the Effectiveness of Intermittent Surface Neuromuscular Stimulation Using the Geko™ Device Compared With Intermittent Pneumatic Compression to Prevent Venous Thromboembolism in Immobile Acute Stroke Patients
NCT05476913 is registered in ClinicalTrials.gov with Firstkind Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Controlled Trial of the Effectiveness of Intermittent Surface Neuromuscular Stimulation Using the Geko™ Device Compared With Intermittent Pneumatic Compression to Prevent Venous Thromboembolism in Immobile Acute Stroke Patients
- Lead sponsor
- Firstkind Ltd
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 6, 2023
- Completion date
- June 30, 2025
- Enrollment
- 1,200 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis, pulmonary embolism, stroke, acute, venous thromboembolism